Answers are grounded in this paper and cite their sources.
Vancomycin has a narrow therapeutic window requiring individualized dosing and repeated monitoring, a process health systems delegate from physicians to pharmacists for consistency. We silently deployed PharmaAgent, LLM-based vancomycin dosing agentic systems, at Stanford Hospital for two months and compared high- and low-autonomy configurations, each with and without institutional guidelines. Across 403 dosing events in 316 patients, mean absolute percentage error against the treating pharmacist's order was 21.8% with high autonomy versus 37.8% with low autonomy, and recommendations were within 25% of the order in 73.4% versus 50.9% of events (P < 0.001); a second pharmacist was within 25% in 90.2%. Pharmacist review of 196 out-of-tolerance recommendations found a safety concern in 65.8%, more often with low autonomy (odds ratio 2.37). A higher-autonomy agent that self-debugged its intermediate steps proved more robust than stricter engineering, but neither configuration is ready to dose patients without pharmacist oversight.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: